相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Hallmarks of Cancer: New Dimensions
Douglas Hanahan
CANCER DISCOVERY (2022)
Autophagy triggers CTSD (cathepsin D) maturation and localization inside cells to promote apoptosis
Yu-Qin Di et al.
AUTOPHAGY (2021)
Early-Onset Colorectal Adenocarcinoma in the IDEA Database: Treatment Adherence, Toxicities, and Outcomes With 3 and 6 Months of Adjuvant Fluoropyrimidine and Oxaliplatin
Elisa Fontana et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Reactivation of the Guardian of the Genome P53: A Promising Strategy for Treatment of Cancer
Ahmed F. Abdel-Magid
ACS Medicinal Chemistry Letters (2021)
Inhibition of the PLK1-Coupled Cell Cycle Machinery Overcomes Resistance to Oxaliplatin in Colorectal Cancer
Zhaoliang Yu et al.
ADVANCED SCIENCE (2021)
WD40 repeat 43 mediates cell survival, proliferation, migration and invasion via vimentin in colorectal cancer
Zijian Li et al.
CANCER CELL INTERNATIONAL (2021)
Molecular implications of MUC5AC-CD44 axis in colorectal cancer progression and chemoresistance
Ramesh Pothuraju et al.
MOLECULAR CANCER (2020)
The PI3K subunits, P110α and P110β are potential targets for overcoming P-gp and BCRP-mediated MDR in cancer
Lei Zhang et al.
MOLECULAR CANCER (2020)
Assessment of Duration and Effects of 3 vs 6 Months of Adjuvant Chemotherapy in High-Risk Stage II Colorectal Cancer A Subgroup Analysis of the TOSCA Randomized Clinical Trial
Fausto Petrelli et al.
JAMA ONCOLOGY (2020)
CALML6 Controls TAK1 Ubiquitination and Confers Protection against Acute Inflammation
Chunjie Sheng et al.
JOURNAL OF IMMUNOLOGY (2020)
RNAi Screening Identifies that TEX10 Promotes the Proliferation of Colorectal Cancer Cells by Increasing NF-κB Activation
Ziyang Wang et al.
ADVANCED SCIENCE (2020)
c-Myc inactivation of p53 through the pan-cancer lncRNA MILIP drives cancer pathogenesis
Yu Chen Feng et al.
NATURE COMMUNICATIONS (2020)
The c-Myc/miR-27b-3p/ATG10 regulatory axis regulates chemoresistance in colorectal cancer
Wu Sun et al.
THERANOSTICS (2020)
p53: 800 million years of evolution and 40 years of discovery
Arnold J. Levine
NATURE REVIEWS CANCER (2020)
The multiple mechanisms that regulate p53 activity and cell fate
Antonina Hafner et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
The EF-Hand Protein CALML6 Suppresses Antiviral Innate Immunity by Impairing IRF3 Dimerization
Ziyang Wang et al.
CELL REPORTS (2019)
RNA Targets Ribogenesis Factor WDR43 to Chromatin for Transcription and Pluripotency Control
Xianju Bi et al.
MOLECULAR CELL (2019)
α-Ketoglutarate-Activated NF-κB Signaling Promotes Compensatory Glucose Uptake and Brain Tumor Development
Xiongjun Wang et al.
MOLECULAR CELL (2019)
Regulation of tNOX expression through the ROS-p53-POU3F2 axis contributes to cellular responses against oxaliplatin in human colon cancer cells
Huei-Yu Chen et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Mutant p53 tunes the NRF2-dependent antioxidant response to support survival of cancer cells
Kamil Lisek et al.
Oncotarget (2018)
Sirtuin 7-mediated deacetylation of WD repeat domain 77 (WDR77) suppresses cancer cell growth by reducing WDR77/PRMT5 transmethylase complex activity
Hao Qi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Revisiting the role of ABC transporters in multidrug-resistant cancer
Robert W. Robey et al.
NATURE REVIEWS CANCER (2018)
The EED protein-protein interaction inhibitor A-395 inactivates the PRC2 complex
Yupeng He et al.
NATURE CHEMICAL BIOLOGY (2017)
WD40 repeat domain proteins: a novel target class?
Matthieu Schapira et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Zefang Tang et al.
NUCLEIC ACIDS RESEARCH (2017)
CIRH1A augments the proliferation of RKO colorectal cancer cells
Feng Guo et al.
ONCOLOGY REPORTS (2017)
Subgroups and prognostication in stage III colon cancer: future perspectives for adjuvant therapy
E. Auclin et al.
ANNALS OF ONCOLOGY (2017)
Evodiamine Suppresses ABCG2 Mediated Drug Resistance by Inhibiting p50/p65 NF-κB Pathway in Colorectal Cancer
Hua Sui et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2016)
Pharmacological targeting of the Wdr5-MLL interaction in C/EBP alpha N-terminal leukemia
Florian Grebien et al.
NATURE CHEMICAL BIOLOGY (2015)
WDSPdb: a database for WD40-repeat proteins
Yang Wang et al.
NUCLEIC ACIDS RESEARCH (2015)
Aberrant gene expression in mucosa adjacent to tumor reveals a molecular crosstalk in colon cancer
Rebeca Sanz-Pamplona et al.
MOLECULAR CANCER (2014)
miR200c Attenuates P-gp-Mediated MDR and Metastasis by Targeting JNK2/c-Jun Signaling Pathway in Colorectal Cancer
Hua Sui et al.
MOLECULAR CANCER THERAPEUTICS (2014)
CDC20 overexpression predicts a poor prognosis for patients with colorectal cancer
Wen-jing Wu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
PDK1 Signaling Toward PLK1-MYC Activation Confers Oncogenic Transformation, Tumor-Initiating Cell Activation, and Resistance to mTOR-Targeted Therapy
Jing Tan et al.
CANCER DISCOVERY (2013)
MDM2, MDMX and p53 in oncogenesis and cancer therapy
Mark Wade et al.
NATURE REVIEWS CANCER (2013)
MiR-30a-5p suppresses tumor growth in colon carcinoma by targeting DTL
Alexander Baraniskin et al.
CARCINOGENESIS (2012)
Complementary Strand MicroRNAs Mediate Acquisition of Metastatic Potential in Colonic Adenocarcinoma
Dung-Tsa Chen et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2012)
Improving Drug Potency and Efficacy by Nanocarrier-Mediated Subcellular Targeting
Mami Murakami et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
A 'metastasis-prone' signature for early-stage mismatch-repair proficient sporadic colorectal cancer patients and its implications for possible therapeutics
Yi Hong et al.
CLINICAL & EXPERIMENTAL METASTASIS (2010)
Effect of statin therapy on colorectal cancer
Marc Bardou et al.
GUT (2010)
WD40 proteins propel cellular networks
Christian U. Stirnimann et al.
TRENDS IN BIOCHEMICAL SCIENCES (2010)
p53 and c-myc How does the cell balance yin and yang?
Mohit Sachdeva et al.
CELL CYCLE (2009)
An expression module of WIPF1-coexpressed genes identifies patients with favorable prognosis in three tumor types
Eike Staub et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2009)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
Association of survival and disease progression with chromosomal instability: A genomic exploration of colorectal cancer
Michal Sheffer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Awakening guardian angels: drugging the p53 pathway
Christopher J. Brown et al.
NATURE REVIEWS CANCER (2009)
Overexpression of OATP1B3 Confers Apoptotic Resistance in Colon Cancer
Wooin Lee et al.
CANCER RESEARCH (2008)
The genetics of the p53 pathway, apoptosis and cancer therapy
Alexei Vazquez et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Transcriptome profile of human colorectal adenomas
Jacob Sabates-Beliver et al.
MOLECULAR CANCER RESEARCH (2007)
p53-R273H gains new function in induction of drug resistance through down-regulation of procaspase-3
Ronald Pak Cheung Wong et al.
MOLECULAR CANCER THERAPEUTICS (2007)
p53 ubiquitination: Mdm2 and beyond
CL Brooks et al.
MOLECULAR CELL (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Characterization of p53 wild-type and null isogenic colorectal cancer cell lines resistant to 5-fluorouracil, oxaliplatin, and irinotecan
J Boyer et al.
CLINICAL CANCER RESEARCH (2004)
Amplification of Mdmx (or Mdm4) directly contributes to tumor formation by inhibiting p53 tumor suppressor activity
D Danovi et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Developmental context determines latency of MYC-induced tumorigenesis
S Beer et al.
PLOS BIOLOGY (2004)
Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway
YP Zhang et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Controlling the false discovery rate in behavior genetics research
Y Benjamini et al.
BEHAVIOURAL BRAIN RESEARCH (2001)
Overexpression of MYC causes p53-dependent G2 arrest of normal fibroblasts
DW Felsher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
